128 related articles for article (PubMed ID: 1707341)
1. The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver.
Aoyagi Y; Suzuki Y; Igarashi K; Saitoh A; Oguro M; Yokota T; Mori S; Nomoto M; Isemura M; Asakura H
Cancer; 1991 May; 67(9):2390-4. PubMed ID: 1707341
[TBL] [Abstract][Full Text] [Related]
2. Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor.
Aoyagi Y; Suzuki Y; Igarashi K; Yokota T; Mori S; Suda T; Naitoh A; Isemura M; Asakura H
Cancer; 1993 Jul; 72(2):615-8. PubMed ID: 7686444
[TBL] [Abstract][Full Text] [Related]
3. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.
Aoyagi Y; Suzuki Y; Isemura M; Nomoto M; Sekine C; Igarashi K; Ichida F
Cancer; 1988 Feb; 61(4):769-74. PubMed ID: 2448024
[TBL] [Abstract][Full Text] [Related]
4. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
Mita Y; Aoyagi Y; Suda T; Asakura H
J Hepatol; 2000 Jun; 32(6):946-54. PubMed ID: 10898315
[TBL] [Abstract][Full Text] [Related]
5. Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.
van Staden L; Bukofzer S; Kew MC; Savage N
J Gastroenterol Hepatol; 1992; 7(3):260-5. PubMed ID: 1377039
[TBL] [Abstract][Full Text] [Related]
6. Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
Yamashita K; Taketa K; Nishi S; Fukushima K; Ohkura T
Cancer Res; 1993 Jul; 53(13):2970-5. PubMed ID: 7686446
[TBL] [Abstract][Full Text] [Related]
7. Lectin-affinity electrophoresis for the detection of AFP microheterogeneities in patients with hepatocellular carcinoma.
Zaninotto M; Ujka F; Lachin M; Bernardi D; Marafi C; Farinati F; Plebani M
Anticancer Res; 1996; 16(1):305-9. PubMed ID: 8615626
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
Aoyagi Y
Glycoconj J; 1995 Jun; 12(3):194-9. PubMed ID: 7496131
[TBL] [Abstract][Full Text] [Related]
9. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
[TBL] [Abstract][Full Text] [Related]
10. The ratio of fucosylation of alpha-fetoprotein in hepatoblastoma.
Tsuchida Y; Honna T; Fukui M; Sakaguchi H; Ishiguro T
Cancer; 1989 Jun; 63(11):2174-6. PubMed ID: 2470490
[TBL] [Abstract][Full Text] [Related]
11. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
[TBL] [Abstract][Full Text] [Related]
12. Molecular discrimination between alpha-fetoprotein from patients with hepatocellular-carcinoma and nonneoplastic liver-diseases by their carbohydrate structures (review).
Aoyagi Y
Int J Oncol; 1994 Feb; 4(2):369-83. PubMed ID: 21566934
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma.
Fujiyama S; Morishita T; Sagara K; Sato T; Motohara K; Matsuda I
Hepatogastroenterology; 1986 Oct; 33(5):201-5. PubMed ID: 2433199
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
16. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.
Viggiani V; Palombi S; Gennarini G; D'Ettorre G; De Vito C; Angeloni A; Frati L; Anastasi E
Scand J Gastroenterol; 2016 Oct; 51(10):1257-62. PubMed ID: 27227515
[TBL] [Abstract][Full Text] [Related]
17. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
[TBL] [Abstract][Full Text] [Related]
18. Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
Bell H
Scand J Gastroenterol; 1982 Oct; 17(7):897-903. PubMed ID: 6186010
[TBL] [Abstract][Full Text] [Related]
19. Plasma abnormal prothrombin (des-gamma-carboxy prothrombin) as a marker of hepatocellular carcinoma.
Fujiyama S; Morishita T; Hashiguchi O; Sato T
Cancer; 1988 Apr; 61(8):1621-8. PubMed ID: 2450634
[TBL] [Abstract][Full Text] [Related]
20. Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma.
Tatsuta M; Yamamura H; Iishi H; Kasugai H; Okuda S
Oncology; 1986; 43(5):306-10. PubMed ID: 2429242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
